The thrombin inhibitor Argatroban reduces breast cancer malignancy and metastasis via osteopontin-dependent and osteopontin-independent mechanisms
Erika B. Schulze, Benjamin D. Hedley, David Goodale, Carl O. Postenka, Waleed Al-Katib, Alan B. Tuck, Ann F. Chambers, Alison L. AllanVolume:
112
Language:
english
Pages:
12
DOI:
10.1007/s10549-007-9865-4
Date:
November, 2008
File:
PDF, 394 KB
english, 2008